198 related articles for article (PubMed ID: 28830571)
1. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
[TBL] [Abstract][Full Text] [Related]
2. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
Michaud HA; de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF
Retrovirology; 2014 Jan; 11():10. PubMed ID: 24472118
[TBL] [Abstract][Full Text] [Related]
3. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
[TBL] [Abstract][Full Text] [Related]
4. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.
SenGupta D; Tandon R; Vieira RG; Ndhlovu LC; Lown-Hecht R; Ormsby CE; Loh L; Jones RB; Garrison KE; Martin JN; York VA; Spotts G; Reyes-Terán G; Ostrowski MA; Hecht FM; Deeks SG; Nixon DF
J Virol; 2011 Jul; 85(14):6977-85. PubMed ID: 21525339
[TBL] [Abstract][Full Text] [Related]
5. Development of an antigen-capture ELISA for the detection of the p27-CA protein of HERV-K(HML-2).
Hohn O; Mostafa S; Norley S; Bannert N
J Virol Methods; 2016 Aug; 234():186-92. PubMed ID: 27142113
[TBL] [Abstract][Full Text] [Related]
6. Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element.
George M; Schwecke T; Beimforde N; Hohn O; Chudak C; Zimmermann A; Kurth R; Naumann D; Bannert N
Retrovirology; 2011 May; 8():30. PubMed ID: 21554716
[TBL] [Abstract][Full Text] [Related]
7. Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.
Jones RB; John VM; Hunter DV; Martin E; Mujib S; Mihajlovic V; Burgers PC; Luider TM; Gyenes G; Sheppard NC; Sengupta D; Tandon R; Yue FY; Benko E; Kovacs C; Nixon DF; Ostrowski MA
Clin Vaccine Immunol; 2012 Feb; 19(2):288-92. PubMed ID: 22205657
[TBL] [Abstract][Full Text] [Related]
8. A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis.
Freimanis G; Hooley P; Ejtehadi HD; Ali HA; Veitch A; Rylance PB; Alawi A; Axford J; Nevill A; Murray PG; Nelson PN
Clin Exp Immunol; 2010 Jun; 160(3):340-7. PubMed ID: 20345981
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Infection of Primary CD4
Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production.
Bhardwaj N; Maldarelli F; Mellors J; Coffin JM
J Virol; 2014 Oct; 88(19):11108-20. PubMed ID: 25056891
[TBL] [Abstract][Full Text] [Related]
11. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.
Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y
AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267
[TBL] [Abstract][Full Text] [Related]
12. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.
Gonzalez-Hernandez MJ; Swanson MD; Contreras-Galindo R; Cookinham S; King SR; Noel RJ; Kaplan MH; Markovitz DM
J Virol; 2012 Aug; 86(15):7790-805. PubMed ID: 22593154
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
[TBL] [Abstract][Full Text] [Related]
14. Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.
Jones RB; Leal FE; Hasenkrug AM; Segurado AC; Nixon DF; Ostrowski MA; Kallas EG
J Negat Results Biomed; 2013 Jan; 12():3. PubMed ID: 23305161
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells.
Michaud HA; SenGupta D; de Mulder M; Deeks SG; Martin JN; Kobie JJ; Sacha JB; Nixon DF
J Immunol; 2014 Aug; 193(4):1544-8. PubMed ID: 25024383
[TBL] [Abstract][Full Text] [Related]
16. HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression.
Kammers K; Chen A; Monaco DR; Hudelson SE; Grant-McAuley W; Moore RD; Alter G; Deeks SG; Morrison CS; Eller LA; Blankson JN; Laeyendecker O; Ruczinski I; Eshleman SH; Larman HB
Front Immunol; 2021; 12():740395. PubMed ID: 34512672
[TBL] [Abstract][Full Text] [Related]
17. Reactivities of HIV-1 gag-derived peptides with antibodies of HIV-1-infected and uninfected humans.
Haist S; März J; Wolf H; Modrow S
AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1909-17. PubMed ID: 1489579
[TBL] [Abstract][Full Text] [Related]
18. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
19. HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors.
Kleiman A; Senyuta N; Tryakin A; Sauter M; Karseladze A; Tjulandin S; Gurtsevitch V; Mueller-Lantzsch N
Int J Cancer; 2004 Jun; 110(3):459-61. PubMed ID: 15095315
[TBL] [Abstract][Full Text] [Related]
20. Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model system.
Kraus B; Fischer K; Sliva K; Schnierle BS
Virol J; 2014 Mar; 11():58. PubMed ID: 24669861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
